Copyright
©The Author(s) 2015.
World J Nephrol. Jul 6, 2015; 4(3): 423-437
Published online Jul 6, 2015. doi: 10.5527/wjn.v4.i3.423
Published online Jul 6, 2015. doi: 10.5527/wjn.v4.i3.423
Figure 3 Effects of 3% hypertonic saline on plasma concentrations of renin (A), angiotensin II (B), aldosterone (C) and arginine vasopressin (D) in 23 healthy subjects pre-treated with bendroflumethiazide, amiloride or placebo.
A-C: There was a significant difference between PRC, p-AngII and p-Aldo plasma levels throughout the study day. Values are means ± SEM. One-way ANOVA was used to test for differences between treatments; D: P-AVP increased significantly at 150 min with a borderline significant difference between treatments (aP = 0.048). Values are medians with upper and lower limits. Friedman’s test was used to test for differences between treatments. BFTZ: Bendroflumethiazide; PRC: Plasma renin concentration.
- Citation: Jensen JM, Mose FH, Kulik AEO, Bech JN, Fenton RA, Pedersen EB. Changes in urinary excretion of water and sodium transporters during amiloride and bendroflumethiazide treatment. World J Nephrol 2015; 4(3): 423-437
- URL: https://www.wjgnet.com/2220-6124/full/v4/i3/423.htm
- DOI: https://dx.doi.org/10.5527/wjn.v4.i3.423